Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZLI vs TIS in Cystic Fibrosis
NCT00757237Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of aztreonam in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Gilead Sciences. Started Aug 2008; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT00757237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757237.